Module 15. Cardiac Sarcoid PET Imaging Clinical Data-Cardiac Sarcoid PET Imaging Clinical Data (Presentation)

Video Transcription

Video Summary

In this video, Ed Miller from Yale discusses cardiac sarcoid PET imaging and clinical data. He provides an overview of the optimal patient preparation for FDG PET imaging for cardiac sarcoidosis and the various methodologies for interpreting FDG PET. Miller also discusses the use of FDG PET for the diagnosis, prognosis, and treatment response of patients with cardiac sarcoidosis.<br /><br />He emphasizes the importance of identifying extracardiac sarcoidosis in order to understand the likelihood of cardiac disease in patients. Miller provides examples of FDG PET scans showing areas of abnormal FDG uptake in the myocardium and in mediastinal and pulmonary parenchymal lymph nodes.<br /><br />Miller also discusses the use of FDG PET in treatment response, noting that patients who have a reduction in FDG signal after treatment with immunosuppression show improvement in their heart function.<br /><br />He concludes by presenting a treatment algorithm that includes cardiac MRI as the initial imaging tool, followed by FDG PET if MRI is inconclusive or for patients presenting with acute heart block. Miller suggests using FDG positivity as a gatekeeper for initiating immunosuppression and repeating FDG PET imaging to monitor treatment response.<br /><br />The video was presented at a conference organized by ASNIC, with credits given to the SNMI ASNIC Expert Consensus Document on the Role of PET-CT in Cardiac Sarcoidosis Detection, Monitoring, and Therapy and the EANM-EACVI ASNIC Guidelines on Procedural Imaging of Imaging, Statement on Imaging in Cardiac Sarcoidosis.

Keywords

cardiac sarcoid PET imaging

clinical data

patient preparation

FDG PET imaging

diagnosis

prognosis